1-3 of 3
Travis S Young
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First in Human Study of an on/Off Switchable CAR-T Cell Platform Targeting CD19 for B Cell Malignancies (CLBR001 + SWI019)

Liana Nikolaenko, Carolyn Mulroney, Peter A. Riedell, Ian W. Flinn, Jose Carlos Cruz, Rakhee Vaidya, Koen van Besien, Michael Emde, Vadim Klyushnichenko, Jonathan Strauss, Eduardo Laborda, Jing Li, Mohit Trikha, Peter G. Schultz, Travis S Young
Journal: Blood
Blood (2021) 138 (Supplement 1): 2822.
https://doi.org/10.1182/blood-2021-151727
Published: 2021
Journal Articles

IND-Enabling Studies of a Switchable Chimeric Antigen Receptor-T Cell (CLBR001+SWI019) to Support First in Human Clinical Study

Eduardo Laborda, Ashley Woods, Andrew Doedens, Yunyi Kang, Vanessa Nunez, Sean Joseph, Michael Emde, Jennifer Stone, Jing Li, Mohit Trikha, Peter G. Schultz, Travis S Young
Journal: Blood
Blood (2021) 138 (Supplement 1): 1695.
https://doi.org/10.1182/blood-2021-149277
Published: 2021
Journal Articles

A Novel Switchable CAR-T Platform for Acute Lymphoblastic Leukemia Treatment

Eduardo Laborda, DVM, PhD, Eric N Hampton, PhD, Sung C Lee, PhD, Ashley K Woods, PhD, Travis S Young, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3890.
https://doi.org/10.1182/blood.V130.Suppl_1.3890.3890
Published: 2017